The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.
Open accessAbstract
BACKGROUND: Severe psoriasis is associated with excess mortality and increased risk of cardiovascular death. Population-based data evaluating cause-specific mortality in patients with psoriasis are limited. OBJECTIVES: To describe cause-specific mortality in patients with severe psoriasis. METHODS: We performed a cohort study from 1987 to 2002 of patients ≥18 years using the General Practice Research Database. We compared patients with a psoriasis code and a history of systemic therapy consistent with severe psoriasis (n=3603) with patients with no history of psoriasis (n=14,330). Age- and sex-adjusted Cox models were created for each of the leading causes of death defined by the Centers for Disease Control. RESULTS: Patients with severe psoriasis were at increased risk of death from cardiovascular disease [hazard ratio (HR) 1·57, 95% confidence interval (CI) 1·26-1·96], malignancies (HR 1·41, 95% CI 1·07-1·86), chronic lower respiratory disease (HR 2·08, 95% CI 1·24-3·48), diabetes (HR 2·86, 95% CI 1·08-7·59), dementia (HR 3·64, 95% CI 1·36-9·72), infection (HR 1·65, 95% CI 1·26-2·18), kidney disease (HR 4·37, 95% CI 2·24-8·53) and unknown/missing causes (HR 1·43, 95% CI 1·09-1·89). The absolute and excess risk of death was highest for cardiovascular disease (61·9 and 3·5 deaths per 1000 patient-years, respectively). CONCLUSIONS: Severe psoriasis is associated with an increased risk of death from a variety of causes, with cardiovascular death being the most common aetiology. These patients were also at increased risk of death from causes not previously reported, such as infection, kidney disease and dementia. Additional studies are necessary to determine the degree to which excess causes of death are due to psoriasis, its treatments, associated behaviours, or other factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Self-citationPendlebury, S. T., & Rothwell, P. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70236-4 · Cited by 1,853
Psoriasis: epidemiology, clinical features, and quality of life
Langley, R. G. B., Krueger, G. G., & Griffiths, C. E. M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033217 · Cited by 1,115
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Prevalence of cardiovascular risk factors in patients with psoriasis
Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.040 · Cited by 1,010
Self-citationKrueger, G. G., Koo, J. Y. M., Lebwohl, M., Menter, A., Stern, R. S., & Rolstad, T. (2001) · PubMed · Cited by 969
Designing clinical research: An epidemiologic approach
(1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90023-8 · Cited by 948
Mehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706
Self-citationValidity of diagnostic coding within the General Practice Research Database: a systematic review
Khan, N. F., Harrison, S. E., & Rose, P. W. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483562 · Cited by 685
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis
Sommer, D. M., Jenisch, S., Suchan, M., Christophers, E., & Weichenthal, M. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0703-z · Cited by 667
Stern, R. S., Nichols, K. T., & Väkevä, L. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361501 · Cited by 656
OLIVIER, C., ROBERT, P. D., DAIHUNG, D., URBÀ, G., CATALIN, M. P., HYWEL, W., Kurd, S. K., Troxel, A. B., Crits-Christoph, P., & Gelfand, J. M. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.186 · Cited by 642
Self-citationThe Psychosocial Burden of Psoriasis
Kimball, A. B., Jacobson, C., Weiss, S., Vreeland, M. G., & Wu, Y. (2005) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200506060-00005 · Cited by 558
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Self-citationKurd, S. K., & Gelfand, J. M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.09.022 · Cited by 519
Self-citationQuality of Life in Patients with Psoriasis: A Systematic Literature Review
de Korte, J., Mombers, F. M. C., Bos, J. D., & Sprangers, M. A. G. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09110.x · Cited by 441
Clinical, educational, and epidemiological value of autopsy
Burton, J. L., & Underwood, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60376-6 · Cited by 440
The Risk of Stroke in Patients with Psoriasis
Gelfand, J. M., Dommasch, E. D., Shin, D. B., Azfar, R. S., Kurd, S. K., Wang, X., & Troxel, A. B. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.112 · Cited by 439
Self-citationKimball, A. B., Gladman, D., Gelfand, J. M., Gordon, K., Horn, E. J., Korman, N. J., Korver, G., Krueger, G. G., Strober, B. E., & Lebwohl, M. G. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.01.006 · Cited by 432
Self-citationIncreased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients
Mallbris, L., Akre, O., Granath, F., Yin, L., Lindelöf, B., Ekbom, A., & Ståhle-Bäckdahl, M. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000020447.59150.f9 · Cited by 390
Miniño, A., Heron, M. P., Murphy, S. L., & Kochanek, K. D. (2007) · PubMed · Cited by 390
Psoriasis: a possible risk factor for development of coronary artery calcification
Ludwig, R. J., Herzog, C., Rostock, A., Ochsendorf, F. R., Zollner, T. M., Thaci, D., Kaufmann, R., Vogl, T. J., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07562.x · Cited by 374
Incidence and Risk Factors for Psoriasis in the General Population
Huerta, C., Rivero, E., & Rodríguez, L. A. G. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1559 · Cited by 343
(2006) · Wiley eBooks · doi:10.1002/9780470059876 · Cited by 342
The Risk of Lymphoma in Patients with Psoriasis
Gelfand, J. M., Shin, D. B., Neimann, A. L., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700410 · Cited by 304
Self-citationPsoriasis and metabolic disease: epidemiology and pathophysiology
Azfar, R. S., & Gelfand, J. M. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283031c99 · Cited by 297
Self-citationChen, J.-H., Lin, K.-P., & Chen, Y.-C. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60402-2 · Cited by 288
SUICIDAL IDEATION IN PSORIASIS
GUPTA, M. A., SCHORK, N. J., GUPTA, A. K., KIRKBY, S., & ELLIS, C. N. (1993) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1993.tb02790.x · Cited by 265
Gelfand, J. M., Berlin, J., Van Voorhees, A., & Margolis, D. J. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.11.1425 · Cited by 249
Self-citationRelationship Between Smoking and the Clinical Severity of Psoriasis
Fortes, C., Mastroeni, S., Leffondré, K., Sampogna, F., Melchi, F., Mazzotti, E., Pasquini, P., & Abeni, D. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1580 · Cited by 246
Psychiatric morbidity in psoriasis: A review
Russo, P. A., Ilchef, R., & Cooper, A. J. (2004) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2004.00078.x · Cited by 227
The risk of malignancy associated with psoriasis.
Margolis, D. J., Bilker, W. B., Hennessy, S., Vittorio, C. C., Santanna, J., & Strom, B. L. (2001) · PubMed · Cited by 226
Comorbidities in Patients with Psoriasis
Gottlieb, A. B., & Dann, F. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.06.021 · Cited by 210
The psychosocial and occupational impact of chronic skin disease
Hong, J., Koo, B., & Koo, J. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00170.x · Cited by 208
Nagai, M., Hoshide, S., & Kario, K. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.212 · Cited by 206
Excess Mortality Related to Alcohol and Smoking Among Hospital-Treated Patients With Psoriasis
Poikolainen, K., Karvonen, J., & Pukkala, E. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.12.1490 · Cited by 200
Brauchli, Y. B., Jick, S. S., Miret, M., & Meier, C. R. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.09020.x · Cited by 187
Wakkee, M., Herings, R. M. C., & Nijsten, T. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.321 · Cited by 173
Visser, K., & van der Heijde, D. M. F. M. (2009) · PubMed · Cited by 169
Psoriasis: depression, anxiety, smoking, and drinking habits
Hayes, J., & Koo, J. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01312.x · Cited by 167
Psoriasis and diabetes: a population‐based cross‐sectional study
Cohen, A., Dreiher, J., Shapiro, Y., Vidavsky, L., Vardy, D., Davidovici, B., & Meyerovitch, J. (2008) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2008.02636.x · Cited by 163
Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155
Alcohol, smoking and psoriasis
Higgins (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00588.x · Cited by 151
Stern, R. S., & Lange, R. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12464847 · Cited by 149
Prey, S., Paul, C. F., Bronsard, V., Puzenat, E., Gourraud, P., Aractingi, S., Aubin, F., Bagot, M., Cribier, B. J., Joly, P., et al. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03564.x · Cited by 143
Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review
McNaull, B. B. A., Todd, S., McGuinness, B., & Passmore, A. P. (2009) · Gerontology · doi:10.1159/000237873 · Cited by 135
Long-term Safety of Cyclosporine in the Treatment of Psoriasis
Grossman, R. (1996) · Archives of Dermatology · doi:10.1001/archderm.132.6.623 · Cited by 128
Comorbidities in Psoriasis Patients
Kim, N., Thrash, B., & Menter, A. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.01.002 · Cited by 126
Psoriasis and the risk of incident diabetes mellitus: a population-based study
Brauchli, Y. B., Jick, S. S., & Meier, C. R. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08814.x · Cited by 125
Psoriasis and chronic obstructive pulmonary disease: a case-control study
Dreiher, J., Weitzman, D., Shapiro, J. S., Davidovici, B. B., & Cohen, A. D. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08749.x · Cited by 114
Epidemiology of comorbidities in psoriasis
Naldi, L., & Mercuri, S. R. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01304.x · Cited by 100
Postal questionnaire study of disability in the community associated with psoriasis
O'Neill, P., & Kelly, P. J. (1996) · BMJ · doi:10.1136/bmj.313.7062.919 · Cited by 90
Depression and Quality of Life in Psoriasis
Voorhees, A. S. V., & Fried, R. G. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.07.2040 · Cited by 84
Is there truly a risk of lymphoma from biologic therapies?
Dommasch, E. D., & Gelfand, J. M. (2009) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2009.01258.x · Cited by 49
Self-citationPsoriasis, the liver, and the gastrointestinal tract
Gisondi, P., Giglio, M. D., Cozzi, A., & Girolomoni, G. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01310.x · Cited by 47
Psoriasis, inflammation, and vascular risk: a problem more than skin deep?
Ridker, P. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq042 · Cited by 25
Mortality and Causes of Death among Psoriatics
Lindegard, B. (2009) · Dermatologica · doi:10.1159/000248321 · Cited by 23
Cited by
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review
Armstrong, A. W., & Read, C. (2020) · JAMA · doi:10.1001/jama.2020.4006 · Cited by 2,335
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,145
Self-citationLangan, S. M., Seminara, N. M., Shin, D. B., Troxel, A. B., Kimmel, S. E., Mehta, N. N., Margolis, D. J., & Gelfand, J. M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.365 · Cited by 525
Self-citation
Metadata
- Authors
- Abuabara, K., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-13
- Volume
- 163
- Issue
- 3
- Pages
- 586-592
- ISSN
- 0007-0963 (ISSN-L)
- OpenAlex
- W1515251814
- Cited by
- 472
- References
- 57
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.